Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Venable

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Journal of Medicinal Chemistry|September 5, 2003
The first potent and selective non-imidazole human histamine H4 receptor antagonistsJill A Jablonowski, Cheryl A Grice, Wenying Chai, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel DiseaseKristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Nature|August 9, 2016
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessShilpi Khare, Advait S Nagle, Agnes Biggart, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Medicinal Chemistry|September 5, 2003
The first potent and selective non-imidazole human histamine H4 receptor antagonistsJill A Jablonowski, Cheryl A Grice, Wenying Chai, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel DiseaseKristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Nature|August 9, 2016
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessShilpi Khare, Advait S Nagle, Agnes Biggart, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
Pageof 12